JMP Securities reiterated their market outperform rating on shares of Notable Labs (NASDAQ:NTBL – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. They currently have a $9.00 target price on the stock.
Separately, Chardan Capital lowered their price objective on shares of Notable Labs from $9.00 to $7.00 and set a buy rating for the company in a research note on Monday.
Read Our Latest Stock Analysis on NTBL
Notable Labs Price Performance
Institutional Trading of Notable Labs
An institutional investor recently bought a new position in Notable Labs stock. Industry Ventures L.L.C. purchased a new stake in shares of Notable Labs, Ltd. (NASDAQ:NTBL – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 204,424 shares of the company’s stock, valued at approximately $386,000. Notable Labs comprises about 0.6% of Industry Ventures L.L.C.’s holdings, making the stock its 6th biggest position. Industry Ventures L.L.C. owned about 9.21% of Notable Labs at the end of the most recent reporting period. Hedge funds and other institutional investors own 70.48% of the company’s stock.
Notable Labs Company Profile
Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic.
Featured Stories
- Five stocks we like better than Notable Labs
- What Does a Stock Split Mean?
- United Airlines Soars on Earnings Beat
- What Are Trending Stocks? Trending Stocks Explained
- J.B. Hunt Hits the Skids: Lower Prices to Come
- 3 Healthcare Dividend Stocks to Buy
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Notable Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Notable Labs and related companies with MarketBeat.com's FREE daily email newsletter.